Covaxin Triggers Immune Response, No Adverse Effects In Phase 1 Trial


New Delhi:

Covaxin, the coronavirus vaccine candidate developed by Hyderabad-based Bharat Biotech, induces an immune response and registered no serious adverse events, the company said Wednesday evening as it released results of Phase I trials.

The vaccine “induced (a) neutralising antibody (an immune response)” and was “well-tolerated in all dose groups with no vaccine-related serious adverse events”, the company said.

“After the first vaccination, local and systemic adverse events were predominantly mild or moderate in severity and resolved rapidly, without any prescribed medication. The most common adverse event was pain at the injection site, which resolved spontaneously,” it added.

Newsbeep

Covaxin is one of three vaccine candidates that has applied to the centre for emergency use authorisation.



Source link

Latest articles

Bollywood actress Kangana Ranaut again targetted Punjabi singer Diljit Dosanjh and actress Priyanka Chopra for expressing solidarity with the farmers...

Covaxin Triggers Immune Response, No Adverse Effects In Phase 1 Trial

New Delhi: Covaxin, the coronavirus vaccine candidate developed by Hyderabad-based Bharat Biotech, induces an immune response and registered no serious adverse events,...

Facebook Says It’s Developing a Tool That Could Read Your Brain; and AI Tool to Summarise News Articles: Report

Facebook is planning on building a neural sensor that will be able to detect people's thoughts and translate them into action, as per...

Infinix Smart HD 2021 to Be Available on December 24 via Flipkart, Snokor A10 Soundbar Launched Alongside

Infinix Smart HD 2021 smartphone has been launched in India and it will be available from December 24 via Flipkart. The price and...
44.1k Followers
Follow

Related articles

Leave a reply

Please enter your comment!
Please enter your name here